Total Payments
$22,806
2024 Payments
$1,075
Companies
23
Transactions
121
Medicare Patients
681
Medicare Billing
$52,401
Payment Breakdown by Category
Consulting$14,829 (65.0%)
Food & Beverage$4,009 (17.6%)
Travel$3,251 (14.3%)
Other$583.59 (2.6%)
Education$133.70 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $14,829 | 10 | 65.0% |
| Food and Beverage | $4,009 | 85 | 17.6% |
| Travel and Lodging | $3,251 | 16 | 14.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $583.59 | 5 | 2.6% |
| Education | $133.70 | 5 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $11,198 | 33 | $0 (2024) |
| Boston Scientific Corporation | $6,341 | 16 | $0 (2024) |
| Acorda Therapeutics, Inc | $2,405 | 8 | $0 (2023) |
| Medtronic USA, Inc. | $736.75 | 6 | $0 (2020) |
| ACADIA Pharmaceuticals Inc | $467.20 | 11 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $300.31 | 5 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $236.02 | 7 | $0 (2024) |
| Biogen, Inc. | $163.93 | 4 | $0 (2024) |
| Kyowa Kirin, Inc. | $154.02 | 4 | $0 (2024) |
| Merz North America, Inc. | $123.34 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,075 | 21 | Supernus Pharmaceuticals, Inc. ($251.35) |
| 2023 | $497.30 | 18 | Boston Scientific Corporation ($131.98) |
| 2022 | $160.62 | 8 | ABBVIE INC. ($48.75) |
| 2021 | $1,588 | 7 | AbbVie Inc. ($913.91) |
| 2020 | $3,911 | 6 | Acorda Therapeutics, Inc ($2,290) |
| 2019 | $12,915 | 32 | AbbVie, Inc. ($7,770) |
| 2018 | $2,280 | 23 | AbbVie, Inc. ($1,217) |
| 2017 | $379.47 | 6 | Medtronic USA, Inc. ($193.38) |
All Payment Transactions
121 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/04/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $19.37 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 10/04/2024 | Cala Health, Inc. | CALA KIQ (Device), CALA TRIO | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: NEUROLOGY | ||||||
| 10/03/2024 | Kyowa Kirin, Inc. | Nourianz (Drug) | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: Adenosine A2A Receptors | ||||||
| 10/02/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $100.80 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 10/01/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $13.21 | General |
| Category: Neuropsychiatry | ||||||
| 10/01/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $11.47 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 10/01/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $6.50 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 09/28/2024 | Ipsen Biopharmaceuticals, Inc | Dysport (Drug) | Food and Beverage | In-kind items and services | $114.49 | General |
| Category: Neurology | ||||||
| 09/27/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $208.70 | General |
| Category: General - DBS_NMD | ||||||
| 09/26/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $22.99 | General |
| Category: NEUROLOGY | ||||||
| 09/25/2024 | Kyowa Kirin, Inc. | Nourianz (Drug) | Food and Beverage | In-kind items and services | $104.32 | General |
| Category: Adenosine A2A Receptors | ||||||
| 06/21/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $22.79 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 06/21/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $0.22 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 06/20/2024 | Kyowa Kirin, Inc. | Nourianz (Drug) | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: Adenosine A2A Receptors | ||||||
| 06/19/2024 | ABBVIE INC. | DUOPA (Drug) | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: NEUROSCIENCE | ||||||
| 06/19/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: Neuropsychiatry | ||||||
| 06/12/2024 | Biogen, Inc. | SKYCLARYS (Drug) | Food and Beverage | In-kind items and services | $90.75 | General |
| Category: Neurology | ||||||
| 06/12/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 06/11/2024 | Biogen, Inc. | TYSABRI (Biological) | Food and Beverage | In-kind items and services | $29.60 | General |
| Category: Neurology | ||||||
| 02/14/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $12.98 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 01/24/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $219.00 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 11/15/2023 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $22.34 | General |
| Category: Neurology | ||||||
| 11/15/2023 | Biogen, Inc. | Skyclarys (Drug) | Food and Beverage | In-kind items and services | $21.20 | General |
| Category: Neurology | ||||||
| 11/13/2023 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 11/09/2023 | Acorda Therapeutics, Inc | INBRIJA (Drug) | Food and Beverage | In-kind items and services | $22.86 | General |
| Category: Parkinson's Disease | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 45 | 55 | $7,982 | $3,197 |
| 2022 | 5 | 78 | 97 | $12,435 | $4,260 |
| 2021 | 7 | 142 | 180 | $27,042 | $11,780 |
| 2020 | 14 | 416 | 545 | $86,665 | $33,163 |
Total Patients
681
Total Services
877
Medicare Billing
$52,401
Procedure Codes
29
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 17 | 20 | $3,400 | $1,758 | 51.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 16 | 19 | $2,166 | $1,215 | 56.1% |
| 95970 | Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator | Office | 2023 | 12 | 16 | $2,416 | $223.65 | 9.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 17 | 18 | $3,060 | $1,441 | 47.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 16 | 18 | $2,052 | $1,140 | 55.6% |
| 95983 | Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator with brain stimulator programming, first 15 minutes with qualified health professional | Office | 2022 | 16 | 22 | $2,574 | $747.03 | 29.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 13 | 15 | $1,125 | $605.50 | 53.8% |
| 95970 | Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator | Office | 2022 | 16 | 24 | $3,624 | $326.06 | 9.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 41 | 50 | $8,500 | $4,263 | 50.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 35 | 41 | $4,674 | $2,550 | 54.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 14 | 17 | $4,012 | $1,864 | 46.5% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 13 | 14 | $3,206 | $1,401 | 43.7% |
| 95983 | Electronic analysis of implanted brain, spinal cord or peripheral stimulation device with brain stimulator programming, first 15 minutes face-to-face time with qualified health care professional | Office | 2021 | 11 | 24 | $2,808 | $901.56 | 32.1% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 16 | 17 | $1,275 | $600.34 | 47.1% |
| 95970 | Electronic analysis of implanted brain, spinal cord or peripheral stimulation device | Office | 2021 | 12 | 17 | $2,567 | $200.46 | 7.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 99 | 127 | $21,590 | $9,460 | 43.8% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 65 | 67 | $15,343 | $6,510 | 42.4% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 37 | 43 | $10,148 | $4,247 | 41.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 45 | 52 | $5,928 | $2,424 | 40.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 25 | 38 | $4,636 | $2,035 | 43.9% |
| 64642 | Injection of chemical for destruction of nerve muscles on arm or leg, 1-4 muscles | Facility | 2020 | 16 | 28 | $6,860 | $1,855 | 27.0% |
| 95983 | Electronic analysis of implanted brain, spinal cord or peripheral stimulation device with brain stimulator programming, first 15 minutes face-to-face time with qualified health care professional | Office | 2020 | 14 | 34 | $3,978 | $1,370 | 34.4% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 12 | 12 | $3,120 | $1,020 | 32.7% |
| 64643 | Injection of chemical for destruction of nerve muscles on arm or leg, 1-4 muscles | Facility | 2020 | 12 | 20 | $3,340 | $997.93 | 29.9% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2020 | 14 | 14 | $2,296 | $986.61 | 43.0% |
About Dr. Christos Sidiropoulos, M.D
Dr. Christos Sidiropoulos, M.D is a Neurology healthcare provider based in East Lansing, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/06/2007. The National Provider Identifier (NPI) number assigned to this provider is 1972794774.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christos Sidiropoulos, M.D has received a total of $22,806 in payments from pharmaceutical and medical device companies, with $1,075 received in 2024. These payments were reported across 121 transactions from 23 companies. The most common payment nature is "Consulting Fee" ($14,829).
As a Medicare-enrolled provider, Sidiropoulos has provided services to 681 Medicare beneficiaries, totaling 877 services with total Medicare billing of $52,401. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location East Lansing, MI
- Active Since 08/06/2007
- Last Updated 09/19/2016
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1972794774
Products in Payments
- Duopa (Drug) $9,086
- GENERAL DBS (Device) $3,119
- INBRIJA (Drug) $2,405
- DUOPA (Drug) $2,113
- GENERAL THERAPIES (Device) $1,089
- GENERAL DBS (Device) $635.82
- GENERAL DBS (Device) $631.97
- GENERAL - DBS (Device) $525.00
- RECLAIM (Device) $520.00
- NUPLAZID (Drug) $467.20
- Qelbree (Drug) $251.35
- ACTIVA (Device) $234.04
- Nourianz (Drug) $154.02
- INGREZZA (Drug) $124.32
- XEOMIN (Biological) $123.34
- Dysport (Drug) $114.49
- NORTHERA (Drug) $93.69
- SKYCLARYS (Drug) $90.75
- AUSTEDO (Drug) $72.16
- APOKYN (Drug) $57.06
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in East Lansing
Dr. Mounzer Yassin-Kassab, M.d, M.D
Neurology — Payments: $386,102
Neurology $386,102
Dr. Jayne Ward, D.o, D.O
Neurology — Payments: $366,840
Neurology $366,840
Dr. Amit Sachdev, M.d., Ms, M.D., MS
Neurology — Payments: $292,376
Neurology $292,376
Dr. Tariq Gheith, M.d, M.D
Neurology — Payments: $218,666
Neurology $218,666
Dr. Larry Charleston, M.d, M.D
Neurology — Payments: $211,437
Neurology $211,437
Dr. Anmar Razak, M.d, M.D
Neurology — Payments: $146,635
Neurology $146,635